Egypt, Sierra Leone sign MoU to boost pharmaceutical cooperation
The Egyptian Drug Authority (EDA) signed a memorandum of understanding (MoU) with the Pharmacy Board of Sierra Leone to enhance bilateral cooperation in pharmaceutical regulation, technical expertise exchange, and capacity building. The agreement was signed by Ali El Ghamrawy, Chairperson
Egypt opens Africa Health ExCon 2026 as Africa CDC chief warns of Ebola threat
Egyptian Prime Minister Mostafa Madbouly on Monday opened the fifth edition of the Africa Health Exhibition and Conference (Africa Health ExCon 2026), where Africa CDC Director-General Jean Kaseya warned of severe continental risks from the Ebola virus epidemic and called
Egypt backs African Medicines Agency, pushes for continent-wide regulatory integration
The Egyptian Drug Authority (EDA) said its chairperson, Ali El-Ghamrawy, participated in a virtual meeting of the African Medicines Agency (AMA) aimed at strengthening regulatory cooperation and integration across the continent. During the meeting, El-Ghamrawy reaffirmed Egypt’s full support for
Egypt’s drug authority discusses market stability with global pharma firms
The head of the Egyptian Drug Authority (EDA) has met with representatives of multinational pharmaceutical companies to discuss mechanisms for strengthening the country’s drug system and supporting investment. EDA Chairman Dr. Ali El-Ghamrawy affirmed the authority’s keenness to enhance its
Egypt accelerates pharmaceutical industry development in state-owned companies
Mohamed El-Shimy, Minister of Public Enterprises, and Ali El-Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA), conducted an extensive field visit to subsidiaries of the Holding Company for Pharmaceuticals, Chemicals, and Medical Supplies. The tour covered Arabian Drug Company (ADCO),
Servier Egypt celebrates jubilee with new production line, cancer programme
Servier Egypt, part of the global Servier Group, has commemorated its 70th anniversary with the opening of a new production line and the launch of the “Access Cancer Treatment (ACT) for Children” initiative. The announcements were made at an